H.C. Wainwright Reaffirms Buy Rating for Legend Biotech (LEGN)
Summary
On April 20, H.C. Wainwright maintained its Buy rating for Legend Biotech Corp. (NASDAQ:LEGN). The firm has projected a target price of $50, which yields more t...
Description
On April 20, H.C. Wainwright maintained its Buy rating for Legend Biotech Corp. (NASDAQ:LEGN). The firm has projected a target price of $50, which yields more t...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source